The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II–III Colorectal Cancer Patients After Curable Resection

por Ying, Hou-Qun, Liao, Yu-Cui, Sun, Fan, Peng, Hong-Xin, Cheng, Xue-Xin
Publicado 2021

High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients

por Ying, Hou-Qun, You, Xia-Hong, Liao, Yu-Cui, Sun, Fan, Cheng, Xue-Xin
Publicado 2021

The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer

por Ying, Hou-Qun, Sun, Fan, Liao, Yu-Cui, Cai, Dan, Yang, Ying, Cheng, Xue-Xin
Publicado 2021

A Novel Prognostic Score Based on ZG16 for Predicting CRC Survival

por Wang, Wei, Sun, Jian-Fang, Wang, Xiao-Zhong, Ying, Hou-Qun, You, Xia-Hong, Sun, Fan
Publicado 2020

Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer

por Ying, Hou-Qun, Chen, Wei, Xiong, Cui-Fen, Wang, Yuanyuan, Li, Xiao-Juan, Cheng, Xue-Xin
Publicado 2022

Application of Machine Learning Algorithms to Predict Lymph Node Metastasis in Early Gastric Cancer

por Tian, HuaKai, Ning, ZhiKun, Zong, Zhen, Liu, Jiang, Hu, CeGui, Ying, HouQun, Li, Hui
Publicado 2022

Platelet‐to‐lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta‐analysis

por Peng, Hong‐Xin, Lin, Kang, He, Bang‐Shun, Pan, Yu‐Qin, Ying, Hou‐Qun, Hu, Xiu‐Xiu, Xu, Tao, Wang, Shu‐Kui
Publicado 2016

Chemotherapy plus bevacizumab as an optimal first-line therapeutic treatment for patients with right-sided metastatic colon cancer: a meta-analysis of first-line clinical trials

por You, Xia-Hong, Jiang, Yu-Huan, Fang, Zhou, Sun, Fan, Li, Yao, Wang, Wei, Xia, Zi-Jin, Wang, Xiao-Zhong, Ying, Hou-Qun
Publicado 2020

Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma

por Liao, Yu-Cui, Ying, Hou-Qun, Huang, Ying, Luo, Yan-Ran, Xiong, Cui-Fen, Nie, Ruo-Wei, Li, Xiao-Juan, Cheng, Xue-Xin
Publicado 2021

Circulating vitamin D binding protein, total, free and bioavailable 25-hydroxyvitamin D and risk of colorectal cancer

por Ying, Hou-Qun, Sun, Hui-Ling, He, Bang-Shun, Pan, Yu-Qin, Wang, Feng, Deng, Qi-Wen, Chen, Jie, Liu, Xian, Wang, Shu-Kui
Publicado 2015

The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy

por Ying, Hou-Qun, Chen, Jie, He, Bang-Shun, Pan, Yu-Qin, Wang, Feng, Deng, Qi-Wen, Sun, Hui-Ling, Liu, Xian, Wang, Shu-Kui
Publicado 2015

Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway

por Wang, Feng, Ying, Hou-Qun, He, Bang-Shun, Pan, Yu-Qin, Deng, Qi-Wen, Sun, Hui-Ling, Chen, Jie, Liu, Xian, Wang, Shu-Kui
Publicado 2015

MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals

por Ying, Hou-Qun, Peng, Hong-Xin, He, Bang-Shun, Pan, Yu-Qin, Wang, Feng, Sun, Hui-Ling, Liu, Xian, Chen, Jie, Lin, Kang, Wang, Shu-Kui
Publicado 2016

Albumin‐to‐fibrinogen ratio as a promising biomarker to predict clinical outcome of non‐small cell lung cancer individuals

por Li, Shu‐Qi, Jiang, Yu‐Huan, Lin, Jin, Zhang, Jing, Sun, Fan, Gao, Qiu‐Fang, Zhang, Lei, Chen, Qing‐Gen, Wang, Xiao‐Zhong, Ying, Hou‐Qun
Publicado 2018

Preoperative circulating FPR and CCF score are promising biomarkers for predicting clinical outcome of stage II–III colorectal cancer patients

por Sun, Fan, Peng, Hong-Xin, Gao, Qiu-Fang, Li, Shu-Qi, Zhang, Jing, Chen, Qing-Gen, Jiang, Yu-Huan, Zhang, Lei, Wang, Xiao-Zhong, Ying, Hou-Qun
Publicado 2018

The involvement of Kras gene 3′-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis

por Ying, Hou-Qun, Wang, Feng, He, Bang-Shun, Pan, Yu-Qin, Gao, Tian-Yi, Xu, Ye-Qiong, Li, Rui, Deng, Qi-Wen, Sun, Hui-Lin, Wang, Shu-Kui
Publicado 2014

Elevated FPR confers to radiochemoresistance and predicts clinical efficacy and outcome of metastatic colorectal cancer patients

por Chen, Qing-Gen, Zhang, Lei, Sun, Fan, Li, Shu-Qi, You, Xia-Hong, Jiang, Yu-Huan, Yang, Wei-Ming, Zhong, Qiong-Hui, Wang, Xiao-Zhong, Ying, Hou-Qun
Publicado 2019

FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer

por Ying, Hou-Qun, Wang, Feng, Chen, Xiao-Lin, He, Bang-Shun, Pan, Yu-Qin, Chen, Jie, Liu, Xian, Cao, Wei-Jun, Peng, Hong-Xin, Lin, Kang, Wang, Shu-Kui
Publicado 2015

Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer

por Zhang, Jing, Li, Shu-Qi, Liao, Zhi-Hua, Jiang, Yu-Huan, Chen, Qing-Gen, Huang, Bo, Liu, Jing, Xu, Yan-Mei, Lin, Jin, Ying, Hou-Qun, Wang, Xiao-Zhong
Publicado 2017

Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients

por You, Xia-Hong, Wen, Can, Xia, Zi-Jin, Sun, Fan, Li, Yao, Wang, Wei, Fang, Zhou, Chen, Qing-Gen, Zhang, Lei, Jiang, Yu-Huang, Wang, Xiao-Zhong, Ying, Hou-Qun, Zong, Zhen
Publicado 2019